Eran Atlas ^UDM

I co-founded DreaMed Diabetes in 2014 with the goal of improving diabetes care with the use of Technology and Information Management after 7 years of developing our technology in Schneider Children's Medical Center of Israel. Our group’s first mission involved the development of an artificial pancreas system - the Holy Grail technology for type 1 diabetes.

Eight years later, our mission was accomplished: the GlucoSitter artificial pancreas closed-loop software which we developed and tested was licensed to Medtronic.

We shifted our focus to developing the DreaMeD Advisor, a 360 solution for managing diabetes; an insulin management system that transforms artificial intelligence into Human intelligence and delivers automated optimization of insulin treatment.

DreaMed Diabetes' mission is to simplify the treatment plan for people with diabetes (PWD) by providing Artificial intelligent decision support solutions.